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Abstract
Few studies have examined the impact of weight history. Extant data from the Atherosclerosis
Risk in Communities Study were used to compare risk factors for normal-weight (body mass
index: 18.5–24.9 kg/m2) adults with a history of weight loss (n = 775) with those for persons with
a history of weight maintenance (n = 5,164). In this 1987–1998 US study, the authors also
compared risk factors for preobese (body mass index: 25.0–29.9 kg/m2) adults with a history of
weight gain (n = 1,296) versus weight maintenance (n = 6,721). They used mixed-models
regression to adjust for ethnicity, gender, age, education, field center, smoking, alcohol
consumption, follow-up time, and follow-up body mass index. Compared with adults with a
history of weight maintenance, adults with a 3-year history of weight loss had more favorable total
and low density lipoprotein cholesterol levels and similar glucose, high density lipoprotein
cholesterol, and triglyceride levels. In contrast, preobese adults with a 3-year history of weight
gain had equivalent glucose and lipid levels at follow-up compared with adults with a history of
weight maintenance. These findings suggest that, in addition to current weight, weight history may
impact glucose and lipid levels.
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In the United States, cigarette smoking is the preventable cause of death and disease that is
most influential (1); however, obesity has also become an important cause of preventable
death (2). Evidence suggests that the effects of smoking on health can be reversed by
quitting. Longitudinal studies have shown that the risk of cardiovascular disease decreases
50 percent 1 year after quitting smoking, and, after 15 years, the risk of coronary heart
disease mortality is similar for former and never smokers (3). To our knowledge, analogous
information on the temporal characteristics of cardiovascular disease risk with weight
reduction is not available, although it is well known that fasting glucose and lipid levels
improve with weight loss (4–7), while weight gain is associated with unfavorable changes in
glucose (8–11) and lipid (12–14) levels.
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It seems logical that a price would be paid for past obesity, such that adults of the same
weight would have different risk profiles depending on their weight history. For example,
one could hypothesize that preobese (body mass index (BMI; weight (kg)/height (m)2):
25.0–29.9 kg/m2) and obese (BMI: ≥30.0 kg/m2) adults who lose weight to become normal
weight (BMI: 18.5–24.9 kg/m2) have a more unfavorable risk factor profile than adults who
have maintained a normal weight. The objectives of this study were to determine 1) whether
preobese and obese adults who lose weight over a 3-year or 9-year interval and become
normal weight attain mean levels of cardiovascular disease risk factors similar to those for
normal-weight adults who have maintained their weight over the interval; and 2) whether
normal-weight adults who gain weight over a 3-year or 9-year interval and become preobese
attain mean levels of cardiovascular disease risk factors similar to those for preobese adults
with a history of weight maintenance. Risk factors examined included fasting glucose; total,




The Atherosclerosis Risk in Communities (ARIC) Study is a prospective investigation of the
natural history and etiology of atherosclerosis and cardiovascular disease in four US
communities: Forsyth County, North Carolina; Jackson, Mississippi; the northwestern
suburbs of Minneapolis, Minnesota; and Washington County, Maryland. Baseline data were
collected between 1987 and 1989 on 15,792 adults 45–64 years of age. Three follow-up
visits occurred at approximately 3-year intervals. The details of the study design have been
described previously (15). This study was approved by the University of North Carolina at
Chapel Hill Public Health Institutional Review Board on research involving human subjects.
Measures and covariates
Study participants were asked to fast for 12 hours prior to their clinic visit. Fasting blood
samples were sent to the Central Clinical Chemistry Laboratory in Minneapolis and the
Central Lipid Laboratory in Houston, Texas, for glucose and lipid determination. These
laboratories participated in the Centers for Disease Control and Prevention’s lipids
standardization program, and the Centers for Disease Control and Prevention analyzed the
laboratories continuously. Serum glucose levels were measured by using a hexokinase/
glucose-6-phosphate dehydrogenase method. Total plasma cholesterol (16) and triglycerides
(17) were determined by enzymatic methods. HDL cholesterol was measured after dextran-
magnesium precipitation (18). The Friedewald method was used to calculate LDL
cholesterol (19). LDL cholesterol was not calculated for participants whose triglyceride
levels were ≥400 mg/dl (4.52 mmol/liter).
Age (date of birth), race/ethnicity, and gender were self-reported during the recruitment
phase and were confirmed during the clinic visit. Cigarette smoking and alcoholic beverage
consumption status were assessed at each visit, and participants were classified as current,
former, or never. Educational level was assessed at baseline, and participants were
categorized as having less than a high school education, being a high school graduate, or
having at least some college education. Medication records for the previous 2 weeks were
collected at each visit. The names of all medications were transcribed, coded, and then
mapped to Medi-Span Therapeutic Classification (MTC) codes and American Hospital
Formulary Service Classification Compilation (AHFSCC) codes. MTC codes for vitamin
B3, antihyperlipidemic, and bile sequestrants or AHFSCC code for antilipemic agents were
coded as lipid-lowering medications. Participants self-reported if they used any medications
for diabetes or high blood sugar.
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The participants were weighed without shoes and in a scrub suit to the nearest pound (1
pound = 0.454 kg) by using a beam balance scale at all visits. Their height (without shoes)
was measured to the nearest centimeter by using a metal rule attached to a wall and a
standard triangular headboard. As noted previously, BMI was calculated as weight in
kilograms divided by height in meters squared. Percent weight change was calculated
between consecutive visits (3-year interval) and the first and fourth visits (9-year interval).
Percent weight change was used instead of absolute weight or BMI change because weight
loss goals are often expressed as percentages in clinical settings and are expressed in this
metric in the National Heart, Lung, and Blood Institute’s obesity evidence report (4). Weight
change was categorized as follows: ≥5.0 percent weight loss, 3.1–4.9 percent weight loss;
weight maintenance (within 3.0 percent), 3.1–4.9 percent weight gain, and ≥5.0 percent
weight gain. The bounds for weight maintenance were intentionally narrow because we
preferred a strict definition for this group.
Samples for analyses
African Americans from Washington County or Minneapolis (n = 55) and participants who
classified their ethnicity as other than White or African American (n = 48) were excluded
because there were too few to enable us to conduct ethnic- and center-specific analyses.
Similar trends were observed for each of the three 3-year intervals; therefore, we created a
“stacked” data set for the 3-year analyses such that, for every study participant (11,478
Whites and 4,211 African Americans), one observation was available for each 3-year
interval (N = 47,067 observations). A participant could be assigned different weight history
categories for each of the 3-year intervals.
Weight losers and weight gainers were examined separately since we wanted to compare
glucose and lipid levels for adults with the same BMI at follow-up but different weight
histories. Therefore, we created four separate analysis data sets based on the interval length
(3 years or 9 years), weight change group, and weight status at the beginning and end of the
interval. In the text that follows, the beginning of the study interval is referred to as
“baseline” and the end of the interval as “follow-up.” Analysis data sets for our studies of
weight loss included only those participants who either 1) were normal weight at baseline
and follow-up and maintained their body weight or 2) lost ≥3.0 percent of their body weight
over the interval and their weight status changed from preobese or obese to normal weight.
There were 5,164 normal-weight maintainers and 1,026 previously overweight weight losers
for the 3-year analyses and 1,029 normal-weight maintainers and 347 previously overweight
weight losers for the 9-year analyses. The analysis data sets for our studies of weight gain
included only those participants who either 1) maintained their body weight and were
preobese at baseline and follow-up or 2) gained ≥3.0 percent of their body weight over the
interval and their weight status changed from normal weight to preobese. There were 6,721
preobese weight maintainers and 1,701 previously normal-weight gainers for the 3-year
analyses and 1,316 preobese weight maintainers and 1,043 previously normal-weight
gainers for the 9-year analyses. The general and outcome-specific exclusions for the four
analysis data sets are summarized in table 1.
Statistical analysis
All four ethnic-gender groups were combined for the analyses since we did not find any
significant interactions between gender or ethnicity and weight history groups. Repeated-
measures regression (PROC MIXED procedure with compound symmetry in SAS software,
version 9.1; SAS Institute, Inc., Cary, North Carolina) was used to construct longitudinal
models of 3-year weight history (losing, maintaining, or gaining) (20). Fully adjusted
models included covariates for ethnicity, gender, field center, education, age, smoking
status, alcohol beverage consumption, follow-up BMI, and follow-up time. Models used to
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study glucose were adjusted for diabetes medications at follow-up, and models used to
examine lipids were adjusted for lipid-lowering medications at follow-up.
The LSMEANS option was used with the PROC MIXED procedure (SAS Institute, Inc.) to
estimate the adjusted mean 3-year or 9-year change in outcomes for each weight history
group and to determine whether there were significant differences in the magnitude and
direction of the changes between groups. In addition, mixed models were also used to
estimate the mean risk factor levels at follow-up. The mean changes were determined based
on the population prevalence or mean for each covariate except follow-up BMI, which was
set at 24.0 kg/m2 when we analyzed history of weight loss versus maintaining normal weight
and at 26.0 kg/m2 when we analyzed history of weight gain versus maintaining preobese
weight. To increase the distinction between the weight maintenance group and other weight
change groups, we have chosen not to show results for participants in the 3.1–4.9 percent
weight gain or loss groups.
RESULTS
Demographics
The frequency distributions and the mean values of the demographic characteristics are
shown in table 2 for adults in the analysis data sets created to study history of weight loss
versus maintaining normal weight. For the 3-year analysis, each participant contributed up
to three observations; therefore, the total number of observations was larger than the number
of participants. Normal-weight maintainers were more likely to be White and female than
were weight losers. Mean ages were similar across groups, but weight losers tended to have
less education, be more likely to smoke cigarettes, and be less likely to consume alcoholic
beverages.
The frequency distribution and means for adults in the history of weight gain versus
maintaining preobese weight analysis data sets are shown in table 3. The ethnic distribution
and mean age at follow-up were relatively consistent across the weight history categories for
both intervals examined. A larger percentage of weight gainers compared with preobese
weight maintainers were women. There were some variations in the distribution of low
educational level, current smoking status, and current alcohol beverage consumption
between the weight maintainers and gainers, but no consistent patterns were detected.
History of weight loss versus maintaining normal weight over 3-year and 9-year intervals
Table 4 shows mean BMI, glucose, and lipid levels at baseline and change in the levels in
adults with a history of weight maintenance or weight loss. By design, weight losers had
higher mean BMI levels at baseline and a larger 3-year and 9-year change in BMI than
normal-weight maintainers. Given the patterns in BMI at baseline, it is not surprising that
weight losers had significantly less favorable baseline glucose and lipid levels when
compared with weight maintainers. In general, weight loss was associated with
improvements in the lipid levels; however, 9-year-only changes in glucose were not
statistically different from those for normal-weight maintainers.
Figure 1 contrasts the difference (weight loser minus normal-weight maintainer) in risk
factor levels at follow-up. Differences greater than zero indicate that the risk factor level was
higher in weight losers than normal-weight maintainers. We found that results varied
depending on the outcome. Over the 3-year interval (part A), weight losers had significantly
more favorable (lower) levels of total cholesterol (0.14 mmol/liter) and LDL cholesterol
(0.14 mmol/liter) but similar levels of glucose, HDL cholesterol, and triglycerides at follow-
up compared with weight maintainers. Over the 9-year interval (part B), total cholesterol
(0.20 mmol/liter) and LDL cholesterol (0.20 mmol/liter) levels at follow-up remained
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significantly more favorable among weight losers compared with normal-weight
maintainers. In contrast, glucose levels (0.28 mmol/liter) were significantly more favorable
among normal-weight maintainers.
History of weight gain versus maintaining preobese weight over 3-year and 9-year
intervals
The baseline and mean changes in BMI, glucose, and lipid levels in adults with a history of
weight maintenance or weight gain are shown in table 5. By design, mean BMI at baseline
was significantly lower in adults who gained weight compared with weight maintainers, and
the weight gainers had a significantly larger change in BMI over the 3-year and 9-year
intervals. Weight gainers had significantly less favorable glucose, total cholesterol, LDL
cholesterol, HDL cholesterol, and triglyceride levels at baseline when compared with weight
maintainers after we adjusted for ethnicity, gender, age, and field center. When examining
change in the risk factors, we found significant differences in the magnitude and direction of
the change in glucose (3-year interval only) and lipid levels between weight maintainers and
weight gainers, with increasing risk associated with weight gain over both the 3-year and 9-
year intervals.
The mean differences (weight gainers minus preobese weight maintainers) after adjusting
for covariates and setting BMI at 26.0 kg/m2 are shown in figure 2. Differences greater than
zero indicate that the risk factor level was higher in weight gainers than preobese weight
maintainers. In general, over both intervals, normal-weight adults who gained weight to
become preobese had similar glucose and lipid levels at follow-up compared with preobese
weight maintainers, with significantly more adverse levels for HDL cholesterol (0.04 mmol/
liter) and triglycerides (0.11 mmol/liter) over the 9-year interval.
DISCUSSION
The results from this study showed that overweight adults who lost weight over a 3-year or
9-year interval to become normal weight had more favorable (lower) total cholesterol and
LDL cholesterol levels and similar HDL cholesterol and triglyceride levels compared with
normal-weight adults who had a history of weight maintenance. Overweight adults who lost
weight to become normal weight had similar glucose levels over the 3-year interval but had
less favorable glucose levels over the 9-year interval compared with normal-weight
maintainers.
There is strong evidence that weight loss in preobese and obese adults reduces metabolic
risk factors for diabetes and cardiovascular disease. The Diabetes Prevention Program found
that a lifestyle intervention that achieved a 5–7 percent weight loss reduced diabetes
incidence by 58 percent over 3 years of follow-up (21). Other intervention studies have also
shown that weight loss reduced the incidence of diabetes (22–24); however, associations
between weight change and glucose levels in population-based studies have been mixed,
with studies showing weight loss to be associated with reduced (11, 25), increased (26, 27),
or no (23) effect on the risk of elevated glucose levels. In the current study, we did not find
that beneficial changes in glucose levels were associated with weight loss among subjects
who were not diabetic at baseline.
Several studies have shown that weight loss by lifestyle modification is associated with
reductions in total cholesterol (0–18 percent), LDL cholesterol (3–22 percent), and
triglycerides (2–44 percent) (4). Consistent with other research, we observed reductions in
total cholesterol, LDL cholesterol, and triglycerides with weight loss. The literature on the
effect of weight loss (via lifestyle modification) on HDL cholesterol is inconclusive, with
one review estimating changes of −7 to 27 percent (4). Here, we found weight loss to be
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associated with a significant increase in HDL cholesterol levels over the 3-year and 9-year
intervals.
The emphasis of the current work was not on the effects of weight loss but on the effects of
weight history independent of current weight. It was interesting that adults with a history of
weight loss over the 3-year and 9-year intervals, compared with “BMI-matched” weight
maintainers, had lower levels of total cholesterol and LDL cholesterol. One hypothesis to
explain this finding is that the lower levels were due to negative calorie balance at the time
of the clinic visit. All participants were fasting when blood was drawn, but weight losers
could have been more likely than weight maintainers to be in negative calorie balance for a
period of days or weeks before the measures were obtained, which may have improved their
lipid levels. Several studies have shown that total cholesterol, LDL cholesterol, and
triglycerides decreased significantly during energy restriction (28–32). Weinsier et al. (33)
attempted to separate the effects of energy restriction from those of weight loss. In their
study of postmenopausal obese women, they found that energy restriction tended to have a
greater effect on triglycerides than weight loss did; however, weight loss tended to have a
greater effect on LDL cholesterol than energy restriction did. Furthermore, their findings
suggested that weight loss and energy restriction had independent effects on total and LDL
cholesterol. In contrast, HDL cholesterol improved with energy restriction only. Thus,
energy deficit could be hypothesized as a mechanism for the reductions that we observed in
lipids. It is important to note that although they were not statistically significant, patterns
were similar (more favorable levels among weight losers) for HDL cholesterol and
triglycerides over the 3-year and 9-year intervals.
Just as we do not know the immediate history of energy balance for the adults studied here,
we also do not know the pattern of weight change between clinic visits. Prior to the follow-
up visit, participants could have been in a phase of weight loss, weight maintenance, or
weight regain. The majority of published weight loss studies are interventions of relatively
short duration (often less than 1 year). Longer studies (more than 2 years) have noted that
the improvements in total and LDL cholesterol after short-term weight loss were not
sustained during a weight loss maintenance phase (33, 34). However, improvements in
triglyceride levels were sustained during the weight maintenance phase. Changes in the lipid
levels in adults in the current study did not follow this pattern, and, indeed, we do not know
how many of the weight losers in our study experienced weight loss followed by weight
maintenance.
As with weight loss, the health consequences of excessive weight gain are well documented.
We observed the expected unfavorable changes in risk factors with weight gain. These
changes effectively cancelled out the majority of the difference between the groups that had
existed 3 or 9 years before (likely associated with the differences in baseline weights).
Preobese weight maintainers, compared with weight gainers, had significantly less favorable
HDL cholesterol and triglyceride levels over the 9-year interval. Although not statistically
significant, similar patterns were seen for total cholesterol and LDL cholesterol. This finding
suggests that, at least in the context of our 3-year and 9-year studies, it was not duration of
time that an adult was preobese that was important, but his or her weight when the
measurement was taken. However, Wannamethee and Shaper (25) found that the risk of
developing diabetes was greater among men who were preobese for more than 5 years than
among men with less than a 5-year history of being overweight. These differing results may
be explained by the use of different reference groups (normal-weight maintainers (25) vs.
pre-obese maintainers).
Several investigators have examined the effects of repeatedly losing and gaining weight
(weight cycling) on the risk of developing chronic disease and mortality. The results of these
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studies have been mixed, and a consensus report found no evidence to support the
hypothesis that weight cycling had an adverse effect on risk factors, morbidity, or mortality
(35). Although we measured weight change by using only two time points, this study bears
some resemblance to studies of weight cycling in that we were attempting to examine the
effects of weight change independent of the effects of current weight. It is possible that
some of the inconsistency in the literature on weight cycling (35) may have been caused by
lack of attention to the direction of the last weight change before the outcomes were
evaluated. In the Iowa Women’s Health Study, French et al. (36) found that women whose
weight fluctuation patterns included weight gain (weight loss regain or continuous weight
gain) were at increased odds of developing diabetes and hypertension regardless of their
weight status at age 18 years when compared with weight-stable women whose weight was
normal at age 18 years. Weight-stable women with a BMI of ≥27.3 kg/m2 at age 18 years
were also at increased risk; however, these results were not standardized to a common
follow-up weight, as was done in our analysis. In a weight-cycling study (30 months), Wing
et al. (14) found that participants with large weight cycles had improvements in lipid levels
during the weight-loss phase. However, during the regain phase, their lipid levels did not
exceed the levels for the weight-stable adults. On the basis of these findings, the authors
hypothesized that “weight loss followed by regaining could actually be more beneficial to
overweight persons than remaining obese” (14, p. 1421).
We were interested in assessing the difference between participants with the same follow-up
weight status but different weight histories. Without this restriction, the mean follow-up
BMI could vary significantly between the two weight history groups. For example, if the
weight maintainers tended to be normal weight at follow-up but the weight losers were
predominately overweight at follow-up, then the differences between the two groups could
potentially be the result of residual confounding that was not adequately controlled by the
use of follow-up BMI as a covariate in the model. However, by creating predefined weight
history categories with the same follow-up weight status category, we reduced the
possibility that the differences found between the two groups were due to their follow-up
BMI instead of their previous weight history. In addition, we believe that the two groups as
analyzed convey useful messages with regard to losing weight to become normal weight (a
public health goal) and gaining weight such that one is no longer normal weight (a
circumstance to be avoided).
Often, studies of weight change are conducted among volunteers actively seeking a weight
loss program. In such studies, it is possible to assign adults randomly to exposure groups and
thereby greatly enhance the ability to control for confounding. While it is a simple matter to
randomly assign adults to receive some type of weight loss intervention, it is very difficult
for adults to actually lose weight and maintain it over a period of time as long as 3 years. A
weakness of observational studies, such as that reported here, is no random assignment to
weight loss or gain groups. Nevertheless, this design did provide a feasible mechanism for
observing relatively long-term effects of weight change history. In addition, in contrast to
most randomized weight loss trials, the sample studied here was community based and thus
more representative of free-living populations than samples studied in most clinical trials.
A potential limitation of this study is the lack of information on intentionality of weight
changes. Analysis of the 1989 National Health Interview Survey determined that, among
adults who lost weight, 60 percent reported that the weight loss was intentional (37).
Unintentional weight loss has been associated with poorer health status and smoking (37,
38). In an effort to eliminate weight changes that could be the result of illness, we repeated
the analysis (data not shown) after excluding all weight change greater than 20 percent. We
found similar results; however, it is still possible that some of the weight change could be
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due to illness, which could impact the study findings depending on the underlying cause of
the weight loss.
Other potential factors that could alter or explain the study findings are changes in diet,
physical activity, and smoking status. Because of the design of the Atherosclerosis Risk in
Communities Study, we were unable to examine changes in diet or physical activity over all
3-year intervals or the 9-year interval because those variables were not assessed at every
examination of the cohort. However, subsequent 3-year analysis controlling for diet and/or
physical activity at follow-up produced similar results (data not shown). Very few of the
participants changed their smoking status over the interval. Therefore, we think it unlikely
that changes in diet, physical activity, or smoking status modified the results found in this
study.
Many experts in the treatment of obesity advocate a relatively modest weight loss (5–10
percent) in obese patients (4–7, 39, 40). The recommendation appears to stem from the
recognition that more weight loss will be difficult to attain (41) and the evidence that health
benefits can be obtained from rather modest weight loss (4–7, 39, 40, 42, 43). The benefits
claimed to accompany modest weight loss could lead one to hypothesize that there are no
residual effects of having a history of higher weight. The current study suggests that
preobese and obese adults who lose weight to become normal weight are not predisposed to
less favorable total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels
than normal-weight maintainers but are predisposed to less favorable glucose levels.
Furthermore, preobese adults with a history of being normal weight may have less favorable
HDL cholesterol and triglyceride levels, but their weight history appears not to impact
glucose, total cholesterol, or LDL cholesterol levels. These findings suggest that, in addition
to current weight, weight history may impact glucose and lipid levels.
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Mean differences (and 95% confidence intervals) in glucose and lipids at follow-up for
adults with a history of weight loss compared with those maintaining normal weight over 3-
year (part A) and 9-year (part B) intervals, Atherosclerosis Risk in Communities Study,
1987–1998. All models were adjusted for ethnicity, gender, education, and field center; age,
body mass index (24.0 kg/m2), smoking status, and alcohol beverage consumption status at
follow-up; and follow-up time. Glucose models were also adjusted for use of diabetes
medications at follow-up. Lipid models were also adjusted for use of lipid-lowering
medications at follow-up. *p < 0.05.
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Mean differences (and 95% confidence intervals) in glucose and lipids at follow-up for
adults with a history of weight gain compared with those maintaining preobese weight over
3-year (part A) and 9-year (part B) intervals, Atherosclerosis Risk in Communities Study,
1987–1998. All models were adjusted for ethnicity, gender, education, and field center; age,
body mass index (24.0 kg/m2), smoking status, and alcohol beverage consumption status at
follow-up; and follow-up time. Glucose models were also adjusted for use of diabetes
medications at follow-up. Lipid models were also adjusted for use of lipid-lowering
medications at follow-up. *p < 0.05.
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TABLE 2
Demographic characteristics of adults with a history of weight loss* or of maintaining normal weight† over 3-
year and 9-year intervals, Atherosclerosis Risk in Communities Study, 1987–1998










(≥5.0%) (n = 286)
Ethnicity (% White) 87.6 78.2 87.8 74.1
Gender (% female) 58.9 56.3 57.1 46.2
Age in years (mean (SD‡))§ 59.9 (6.3) 60.5 (6.4) 63.6 (5.5) 65.2 (5.7)
Education (% less than high school) 14.2 21.5 13.4 26.8
Cigarette smoking status (% current)§ 23.0 29.7 19.9 31.1
Alcoholic beverage consumers (%
current)§
61.6 48.2 55.6 44.0
*
Preobese (body mass index: 25.0–29.9 kg/m2) or obese (body mass index: ≥30.0 kg/m2) at baseline and lost ≥ 5.0% of their body weight to
become normal weight (body mass index: 18.5–24.9 kg/m2) at follow-up.
†
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TABLE 3
Demographic characteristics of adults with a history of weight gain* or of maintaining preobese weight† over
3-year and 9-year intervals, Atherosclerosis Risk in Communities Study, 1987–1998











(≥5.0%) (n = 946)
Ethnicity (% White) 79.7 83.1 79.5 83.0
Gender (% female) 39.8 67.3 37.4 69.0
Age in years (mean (SD‡))§ 60.3 (6.2) 58.6 (6.0) 63.7 (5.6) 61.7 (5.6)
Education (% less than high school) 19.3 17.0 19.4 13.4
Cigarette smoking status (% current)§ 17.6 18.8 13.7 13.4
Alcoholic beverage consumers (%
current)§
56.9 56.7 53.6 55.9
*
Normal weight (body mass index: 18.5–24.9 kg/m2) at baseline and gained ≥5.0% of their body weight to become preobese (body mass index:
25.0–29.9 kg/m2) at follow-up.
†
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